Last 12 months
Inside the activity.
0 purchase rows · 13 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 0 | 1 |
| Dec 2025 | 0 | 0 |
| Jan 2026 | 0 | 0 |
| Feb 2026 | 0 | 12 |
| Mar 2026 | 0 | 0 |
| Apr 2026 | 0 | 0 |
| May 2026 | 0 | 0 |
| Jun 2026 | 0 | 0 |
| Jul 2026 | 0 | 0 |
| Aug 2026 | 0 | 0 |
| Sep 2026 | 0 | 0 |
| Oct 2026 | 0 | 0 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| August 02, 2017 Filed Feb 2, 2018 19:52 UTC |
Morrow J WilliamSVP - Finance and Treasurer
|
GiftCommon Stock | 26 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-18-007235 · doc4.xml · nonDerivative · entry 3 Morrow J William · CIK 0001696543 · SVP - Finance and Treasurer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,355.5358 F1 · balance_after: Includes 722.5358 shares acquired under the HCA Holdings, Inc. Employee Stock Purchase Plan. Read SEC document |
| July 17, 2017 Filed Jul 19, 2017 22:30 UTC |
Cuffe Michael S.President-Physician Services
|
Exercise / conversionNon-Qualified Stock Option (right to buy) · Derivative | 2,150 | $0.00 Strike: $17.33 | $0.00 |
DisclosureSEC source: 0001209191-17-045742 · doc4.xml · derivative · entry 3 Cuffe Michael S. · CIK 0001632835 · President-Physician Services 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 11,000 Underlying: Common Stock · 2,150 shares Expires 2021-11-02 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The option exercises and sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person. F2 · derivative.exercise_date: The option vested in two equal annual installments beginning on November 2, 2014. Read SEC document |
| July 17, 2017 Filed Jul 19, 2017 22:30 UTC |
Cuffe Michael S.President-Physician Services
|
SaleCommon Stock | 2,150 | $86.44 | $185,846.00 |
DisclosureSEC source: 0001209191-17-045742 · doc4.xml · nonDerivative · entry 2 Cuffe Michael S. · CIK 0001632835 · President-Physician Services 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,212.555 F1 · kind: The option exercises and sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person. Read SEC document |
| July 17, 2017 Filed Jul 19, 2017 22:30 UTC |
Cuffe Michael S.President-Physician Services
|
Exercise / conversionCommon Stock | 2,150 | $17.33 | $37,259.50 |
DisclosureSEC source: 0001209191-17-045742 · doc4.xml · nonDerivative · entry 1 Cuffe Michael S. · CIK 0001632835 · President-Physician Services 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 12,362.555 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The option exercises and sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person. Read SEC document |
| June 22, 2017 Filed Jun 26, 2017 22:09 UTC |
Perlin Jonathan BPres-Clinical Services & CMO
|
Exercise / conversionNon-Qualified Stock Option (right to buy) · Derivative | 25,000 | $0.00 Strike: $13.53 | $0.00 |
DisclosureSEC source: 0001209191-17-041861 · doc4.xml · derivative · entry 9 Perlin Jonathan B · CIK 0001373493 · Pres-Clinical Services & CMO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 13,418 Underlying: Common Stock · 25,000 shares Expires 2017-11-15 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_price: Exercise Price was adjusted to reflect a 4.505 to 1 stock split that occurred with respect to the Issuer's common stock effective March 9, 2011. F1 · kind: The option exercises and sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person. F6 · derivative.exercise_date: The option vested in two equal annual installments beginning on November 15, 2008. F5 · derivative.underlying_shares: Shares have been adjusted to reflect a 4.505 to 1 stock split that occurred with respect to the Issuer's common stock effective March 9, 2011. Read SEC document |
| June 22, 2017 Filed Jun 26, 2017 22:09 UTC |
Perlin Jonathan BPres-Clinical Services & CMO
|
Exercise / conversionNon-Qualified Stock Option (right to buy) · Derivative | 19,209 | $0.00 Strike: $8.54 | $0.00 |
DisclosureSEC source: 0001209191-17-041861 · doc4.xml · derivative · entry 8 Perlin Jonathan B · CIK 0001373493 · Pres-Clinical Services & CMO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 19,209 shares Expires 2017-11-15 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_price: Exercise Price was adjusted to reflect a 4.505 to 1 stock split that occurred with respect to the Issuer's common stock effective March 9, 2011. F1 · kind: The option exercises and sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person. F5 · derivative.underlying_shares: Shares have been adjusted to reflect a 4.505 to 1 stock split that occurred with respect to the Issuer's common stock effective March 9, 2011. Read SEC document |
| June 22, 2017 Filed Jun 26, 2017 22:09 UTC |
Perlin Jonathan BPres-Clinical Services & CMO
|
Exercise / conversionNon-Qualified Stock Option (right to buy) · Derivative | 26,854 | $0.00 Strike: $5.78 | $0.00 |
DisclosureSEC source: 0001209191-17-041861 · doc4.xml · derivative · entry 7 Perlin Jonathan B · CIK 0001373493 · Pres-Clinical Services & CMO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 26,854 shares Expires 2017-11-15 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_price: Exercise Price was adjusted to reflect a 4.505 to 1 stock split that occurred with respect to the Issuer's common stock effective March 9, 2011. F1 · kind: The option exercises and sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person. F4 · derivative.exercise_date: The option vested in two equal annual installments beginning on November 15, 2011. F5 · derivative.underlying_shares: Shares have been adjusted to reflect a 4.505 to 1 stock split that occurred with respect to the Issuer's common stock effective March 9, 2011. Read SEC document |
| June 22, 2017 Filed Jun 26, 2017 22:09 UTC |
Perlin Jonathan BPres-Clinical Services & CMO
|
SaleCommon Stock | 71,063 | $86.00 | $6,111,418.00 |
DisclosureSEC source: 0001209191-17-041861 · doc4.xml · nonDerivative · entry 4 Perlin Jonathan B · CIK 0001373493 · Pres-Clinical Services & CMO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 14,911.6115 F1 · kind: The option exercises and sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person. F2 · balance_after: Includes 1,220.6115 shares acquired under the HCA Holdings, Inc. Employee Stock Purchase Plan Read SEC document |
| June 22, 2017 Filed Jun 26, 2017 22:09 UTC |
Perlin Jonathan BPres-Clinical Services & CMO
|
Exercise / conversionCommon Stock | 25,000 | $13.53 | $338,347.50 |
DisclosureSEC source: 0001209191-17-041861 · doc4.xml · nonDerivative · entry 3 Perlin Jonathan B · CIK 0001373493 · Pres-Clinical Services & CMO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 85,974.6115 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The option exercises and sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person. F2 · balance_after: Includes 1,220.6115 shares acquired under the HCA Holdings, Inc. Employee Stock Purchase Plan Read SEC document |
| June 22, 2017 Filed Jun 26, 2017 22:09 UTC |
Perlin Jonathan BPres-Clinical Services & CMO
|
Exercise / conversionCommon Stock | 19,209 | $8.54 | $164,033.33 |
DisclosureSEC source: 0001209191-17-041861 · doc4.xml · nonDerivative · entry 2 Perlin Jonathan B · CIK 0001373493 · Pres-Clinical Services & CMO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 60,974.6115 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The option exercises and sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person. F2 · balance_after: Includes 1,220.6115 shares acquired under the HCA Holdings, Inc. Employee Stock Purchase Plan Read SEC document |
| June 22, 2017 Filed Jun 26, 2017 22:09 UTC |
Perlin Jonathan BPres-Clinical Services & CMO
|
Exercise / conversionCommon Stock | 26,854 | $5.78 | $155,342.33 |
DisclosureSEC source: 0001209191-17-041861 · doc4.xml · nonDerivative · entry 1 Perlin Jonathan B · CIK 0001373493 · Pres-Clinical Services & CMO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 41,765.6115 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The option exercises and sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person. F2 · balance_after: Includes 1,220.6115 shares acquired under the HCA Holdings, Inc. Employee Stock Purchase Plan Read SEC document |
| June 15, 2017 Filed Jun 19, 2017 21:25 UTC |
Cuffe Michael S.President-Physician Services
|
Exercise / conversionNon-Qualified Stock Option (right to buy) · Derivative | 2,150 | $0.00 Strike: $17.33 | $0.00 |
DisclosureSEC source: 0001209191-17-040886 · doc4.xml · derivative · entry 3 Cuffe Michael S. · CIK 0001632835 · President-Physician Services 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 13,150 Underlying: Common Stock · 2,150 shares Expires 2021-11-02 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The option exercises and sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person. F3 · derivative.exercise_date: The option vested in two equal annual installments beginning on November 2, 2014. Read SEC document |
| June 15, 2017 Filed Jun 19, 2017 21:25 UTC |
Cuffe Michael S.President-Physician Services
|
SaleCommon Stock | 2,150 | $84.86 | $182,449.00 |
DisclosureSEC source: 0001209191-17-040886 · doc4.xml · nonDerivative · entry 2 Cuffe Michael S. · CIK 0001632835 · President-Physician Services 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,212.555 F1 · kind: The option exercises and sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person. F2 · balance_after: Includes 1,230.555 shares acquired under the HCA Holdings, Inc. Employee Stock Purchase Plan. Read SEC document |
| June 15, 2017 Filed Jun 19, 2017 21:25 UTC |
Cuffe Michael S.President-Physician Services
|
Exercise / conversionCommon Stock | 2,150 | $17.33 | $37,259.50 |
DisclosureSEC source: 0001209191-17-040886 · doc4.xml · nonDerivative · entry 1 Cuffe Michael S. · CIK 0001632835 · President-Physician Services 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 12,362.555 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The option exercises and sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person. F2 · balance_after: Includes 1,230.555 shares acquired under the HCA Holdings, Inc. Employee Stock Purchase Plan. Read SEC document |
| May 23, 2017 Filed May 25, 2017 21:29 UTC |
Davis Jana JoustraSVP - Mktg. & Corp. Affairs
|
Exercise / conversionStock Appreciation Right · Derivative | 2,562 | $0.00 Strike: $69.58 | $0.00 |
DisclosureSEC source: 0001209191-17-035514 · doc4.xml · derivative · entry 13 Davis Jana Joustra · CIK 0001513409 · SVP - Mktg. & Corp. Affairs 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,688 Underlying: Common Stock · 2,562 shares Expires 2026-01-29 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F7 · derivative.exercise_date: The stock appreciation rights vest in four equal annual installments beginning on January 29, 2017. Read SEC document |
| May 23, 2017 Filed May 25, 2017 21:29 UTC |
Davis Jana JoustraSVP - Mktg. & Corp. Affairs
|
Exercise / conversionStock Appreciation Right · Derivative | 5,500 | $0.00 Strike: $68.96 | $0.00 |
DisclosureSEC source: 0001209191-17-035514 · doc4.xml · derivative · entry 12 Davis Jana Joustra · CIK 0001513409 · SVP - Mktg. & Corp. Affairs 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,500 Underlying: Common Stock · 5,500 shares Expires 2025-02-04 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F6 · derivative.exercise_date: The stock appreciation rights vest in four equal annual installments beginning on February 4, 2016. Read SEC document |
| May 23, 2017 Filed May 25, 2017 21:29 UTC |
Davis Jana JoustraSVP - Mktg. & Corp. Affairs
|
Exercise / conversionStock Appreciation Right · Derivative | 12,250 | $0.00 Strike: $47.97 | $0.00 |
DisclosureSEC source: 0001209191-17-035514 · doc4.xml · derivative · entry 11 Davis Jana Joustra · CIK 0001513409 · SVP - Mktg. & Corp. Affairs 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 12,250 shares Expires 2024-02-05 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F5 · derivative.exercise_date: The stock appreciation rights vested at the end of fiscal years 2014, 2015 and 2016 based upon the achievement of certain annual EBITDA performance targets. Read SEC document |
| May 23, 2017 Filed May 25, 2017 21:29 UTC |
Davis Jana JoustraSVP - Mktg. & Corp. Affairs
|
Exercise / conversionStock Appreciation Right · Derivative | 13,125 | $0.00 Strike: $47.97 | $0.00 |
DisclosureSEC source: 0001209191-17-035514 · doc4.xml · derivative · entry 10 Davis Jana Joustra · CIK 0001513409 · SVP - Mktg. & Corp. Affairs 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,375 Underlying: Common Stock · 13,125 shares Expires 2024-02-05 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · derivative.exercise_date: The stock appreciation rights vest in four equal annual installments beginning on February 5, 2015. Read SEC document |
| May 23, 2017 Filed May 25, 2017 21:29 UTC |
Davis Jana JoustraSVP - Mktg. & Corp. Affairs
|
Exercise / conversionStock Appreciation Right · Derivative | 23,750 | $0.00 Strike: $37.18 | $0.00 |
DisclosureSEC source: 0001209191-17-035514 · doc4.xml · derivative · entry 9 Davis Jana Joustra · CIK 0001513409 · SVP - Mktg. & Corp. Affairs 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 23,750 shares Expires 2023-02-06 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_date: The stock appreciation rights vested at the end of fiscal years 2013, 2014, 2015 and 2016 based upon the achievement of certain annual EBITDA performance targets. Read SEC document |
| May 23, 2017 Filed May 25, 2017 21:29 UTC |
Davis Jana JoustraSVP - Mktg. & Corp. Affairs
|
Exercise / conversionStock Appreciation Right · Derivative | 25,000 | $0.00 Strike: $37.18 | $0.00 |
DisclosureSEC source: 0001209191-17-035514 · doc4.xml · derivative · entry 8 Davis Jana Joustra · CIK 0001513409 · SVP - Mktg. & Corp. Affairs 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 25,000 shares Expires 2023-02-06 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: The stock appreciation rights vested in four equal annual installments beginning on February 6, 2014. Read SEC document |
| May 23, 2017 Filed May 25, 2017 21:29 UTC |
Davis Jana JoustraSVP - Mktg. & Corp. Affairs
|
SaleCommon Stock | 54,689 | $82.35 | $4,503,677.43 |
DisclosureSEC source: 0001209191-17-035514 · doc4.xml · nonDerivative · entry 6 Davis Jana Joustra · CIK 0001513409 · SVP - Mktg. & Corp. Affairs 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 26,378 F1 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $82.00 to $82.48, inclusive. The reporting person undertakes to provide to HCA Healthcare, Inc., any security holder of HCA Healthcare, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| May 23, 2017 Filed May 25, 2017 21:29 UTC |
Davis Jana JoustraSVP - Mktg. & Corp. Affairs
|
Tax withholdingCommon Stock | 59,902 | $81.93 | $4,907,770.86 |
DisclosureSEC source: 0001209191-17-035514 · doc4.xml · nonDerivative · entry 5 Davis Jana Joustra · CIK 0001513409 · SVP - Mktg. & Corp. Affairs 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 81,427 Read SEC document |
| May 23, 2017 Filed May 25, 2017 21:29 UTC |
Davis Jana JoustraSVP - Mktg. & Corp. Affairs
|
Exercise / conversionCommon Stock | 2,562 | $69.58 | $178,263.96 |
DisclosureSEC source: 0001209191-17-035514 · doc4.xml · nonDerivative · entry 4 Davis Jana Joustra · CIK 0001513409 · SVP - Mktg. & Corp. Affairs 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 141,329 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| May 23, 2017 Filed May 25, 2017 21:29 UTC |
Davis Jana JoustraSVP - Mktg. & Corp. Affairs
|
Exercise / conversionCommon Stock | 5,500 | $68.96 | $379,280.00 |
DisclosureSEC source: 0001209191-17-035514 · doc4.xml · nonDerivative · entry 3 Davis Jana Joustra · CIK 0001513409 · SVP - Mktg. & Corp. Affairs 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 138,767 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| May 23, 2017 Filed May 25, 2017 21:29 UTC |
Davis Jana JoustraSVP - Mktg. & Corp. Affairs
|
Exercise / conversionCommon Stock | 25,375 | $47.97 | $1,217,238.75 |
DisclosureSEC source: 0001209191-17-035514 · doc4.xml · nonDerivative · entry 2 Davis Jana Joustra · CIK 0001513409 · SVP - Mktg. & Corp. Affairs 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 133,267 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| May 23, 2017 Filed May 25, 2017 21:29 UTC |
Davis Jana JoustraSVP - Mktg. & Corp. Affairs
|
Exercise / conversionCommon Stock | 48,750 | $37.18 | $1,812,525.00 |
DisclosureSEC source: 0001209191-17-035514 · doc4.xml · nonDerivative · entry 1 Davis Jana Joustra · CIK 0001513409 · SVP - Mktg. & Corp. Affairs 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 107,892 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| May 22, 2017 Filed Feb 14, 2018 17:39 UTC |
Frist William RDirector · 10% owner
|
GiftCommon Stock, par value $0.01 per share | 9,366.67 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-18-010037 · doc5.xml · nonDerivative · entry 1 Frist William R · CIK 0001433377 · Director · 10% owner 10b5-1 filing: Not disclosed Ownership: Indirect · Held indirectly through Hercules Holding II by William Frist May 2017 GRAT Disclosed balance after: 9,366.67 F1 · ownership.nature: Hercules Holding II ("Hercules") holds 68,912,077 shares of the common stock of HCA Healthcare, Inc. Hercules is held by a private investor group, including affiliates of HCA Inc. founder Dr. Thomas F. Frist Jr. The Reporting Person may be deemed to be a member of a group exercising voting and investment control over the shares of common stock of HCA Healthcare, Inc. held by Hercules. However, the Reporting Person disclaims membership in any such group and disclaims beneficial ownership of these securities, except to the extent of his pecuniary interest therein. F2 · ownership.nature: The Reporting Person received a gift of 9,366.67 units of Hercules on May 22, 2017, which were subsequently transferred to The William Frist May 2017 GRAT, of which he serves as trustee. Following receipt of this gift, the Reporting Person may be deemed the beneficial owner of the units of Hercules held by this trust and therefore may be deemed to own indirectly the same number of shares of common stock of HCA Healthcare, Inc. Read SEC document |
| May 22, 2017 Filed Feb 14, 2018 17:39 UTC |
FRIST PATRICIA C10% owner
|
GiftCommon Stock, par value $0.01 per share | 28,100 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-18-010034 · doc5.xml · nonDerivative · entry 1 FRIST PATRICIA C · CIK 0001181963 · 10% owner 10b5-1 filing: Not disclosed Ownership: Indirect · Held indirectly through Hercules Holding II by Patricia Champion Frist 2015 GRAT Disclosed balance after: 0 F1 · ownership.nature: Hercules Holding II ("Hercules") holds 68,912,077 shares of the common stock of HCA Healthcare, Inc. Hercules is held by a private investor group, including affiliates of HCA Inc. founder Dr. Thomas F. Frist Jr. The Reporting Person may be deemed to be a member of a group exercising voting and investment control over the shares of common stock of HCA Healthcare, Inc. held by Hercules. However, the Reporting Person disclaims membership in any such group and disclaims beneficial ownership of these securities, except to the extent of her pecuniary interest therein. F2 · ownership.nature: The Reporting Person's spouse is trustee of (i) Patricia Champion Frist 2015 Grantor Retained Annuity Trust, (ii) Thomas F. Frist GST Tax Exempt Trust and (iii) Patricia Champion Frist 2017 Grantor Retained Annuity Trust, and the Reporting Person may therefore be deemed to be the beneficial owner of the units of Hercules held by these trusts and therefore may be deemed to own indirectly the same number of shares of common stock of HCA Healthcare, Inc. Read SEC document |
| May 22, 2017 Filed Feb 14, 2018 17:39 UTC |
FRIST THOMAS F JR10% owner
|
GiftCommon Stock, par value $0.01 per share | 28,100 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-18-010031 · doc5.xml · nonDerivative · entry 1 FRIST THOMAS F JR · CIK 0000900596 · 10% owner 10b5-1 filing: Not disclosed Ownership: Indirect · Held indirectly through Hercules Holding II by Patricia Champion Frist 2015 GRAT Disclosed balance after: 0 F1 · ownership.nature: Hercules Holding II ("Hercules") holds 68,912,077 shares of the common stock of HCA Healthcare, Inc. Hercules is held by a private investor group, including affiliates of HCA Inc. founder Dr. Thomas F. Frist Jr. The Reporting Person may be deemed to be a member of a group exercising voting and investment control over the shares of common stock of HCA Healthcare, Inc. held by Hercules. However, the Reporting Person disclaims membership in any such group and disclaims beneficial ownership of these securities, except to the extent of his pecuniary interest therein. F2 · ownership.nature: The Reporting Person is trustee of (i) Patricia Champion Frist 2015 Grantor Retained Annuity Trust, (ii) Thomas F. Frist GST Tax Exempt Trust and (iii) Patricia Champion Frist 2017 Grantor Retained Annuity Trust and may be deemed to be the beneficial owner of the units of Hercules held by these trusts and therefore may be deemed to own indirectly the same number of shares of common stock of HCA Healthcare, Inc. Read SEC document |
| May 22, 2017 Filed Feb 14, 2018 17:39 UTC |
FRIST THOMAS F IIIDirector · 10% owner
|
GiftCommon Stock, par value $0.01 per share | 9,366.66 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-18-010025 · doc5.xml · nonDerivative · entry 1 FRIST THOMAS F III · CIK 0001223892 · Director · 10% owner 10b5-1 filing: Not disclosed Ownership: Indirect · Held indirectly through Hercules Holding II by Thomas F. Frist III 2017 Annuity Trust I Disclosed balance after: 1,088,856.0364 F1 · ownership.nature: Hercules Holding II ("Hercules") holds 68,912,077 shares of the common stock of HCA Healthcare, Inc. Hercules is held by a private investor group, including affiliates of HCA Inc. founder Dr. Thomas F. Frist Jr. The Reporting Person may be deemed to be a member of a group exercising voting and investment control over the shares of common stock of HCA Healthcare, Inc. held by Hercules. However, the Reporting Person disclaims membership in any such group and disclaims beneficial ownership of these securities, except to the extent of his pecuniary interest therein. F2 · ownership.nature: The Reporting Person received a gift of 9,366.66 units of Hercules on May 22, 2017, which were subsequently transferred to The Thomas F. Frist III 2017 Annuity Trust I, of which he serves as trustee. Following receipt of this gift, the Reporting Person may be deemed the beneficial owner of the units of Hercules held by this trust and therefore may be deemed to own indirectly the same number of shares of common stock of HCA Healthcare, Inc. Read SEC document |
| May 22, 2017 Filed Feb 14, 2018 17:38 UTC |
Elcan Patricia F10% owner
|
GiftCommon Stock, par value $0.01 per share | 38,979.5002 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-18-010020 · doc5.xml · nonDerivative · entry 4 Elcan Patricia F · CIK 0001433376 · 10% owner 10b5-1 filing: Not disclosed Ownership: Indirect · Held indirectly by GRATs Disclosed balance after: 3,449,230.4752 F1 · ownership.nature: Hercules Holding II ("Hercules") holds 68,912,077 shares of the common stock of HCA Healthcare, Inc. Hercules is held by a private investor group, including affiliates of HCA Inc. founder Dr. Thomas F. Frist Jr. The Reporting Person may be deemed to be a member of a group exercising voting and investment control over the shares of common stock of HCA Healthcare, Inc. held by Hercules. However, the Reporting Person disclaims membership in any such group and disclaims beneficial ownership of these securities, except to the extent of her pecuniary interest therein. F2 · ownership.nature: The Reporting Person is trustee of three grantor retained annuity trusts for the benefit of her children, and the Reporting Person's spouse is the trustee of nine grantor retained annuity trusts for the benefit of the Reporting Person's children. The Reporting Person may, accordingly, be deemed to be the beneficial owner of the aggregate of 35,190 shares of common stock of HCA Healthcare, Inc. held by such trusts. In addition, the Reporting Person may be deemed to be the beneficial owner of the 3,466,416.4752 units of Hercules held by such trusts and therefore may be deemed to own indirectly the same number of shares of common stock of HCA Healthcare, Inc. F5 · ownership.nature: On May 22, 2017, The Patricia Frist Elcan 2015 Annuity Trust I transferred an aggregate of 38,979.5002 units of Hercules to three grantor retained annuity trusts for the benefit of the Reporting Person's children. The Reporting Person is trustee of The Patricia Frist Elcan 2015 Annuity Trust I and the Reporting Person's spouse is trustee of the three grantor retained annuity trusts for the benefit of the Reporting Person's children. The Reporting Person may therefore be deemed the beneficial owner of the units of Hercules held by these grantor retained annuity trusts and therefore may be deemed to own indirectly the same number of shares of common stock of HCA Healthcare, Inc. Read SEC document |
| May 22, 2017 Filed Feb 14, 2018 17:38 UTC |
Elcan Patricia F10% owner
|
GiftCommon Stock, par value $0.01 per share | 38,979.5002 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-18-010020 · doc5.xml · nonDerivative · entry 3 Elcan Patricia F · CIK 0001433376 · 10% owner 10b5-1 filing: Not disclosed Ownership: Indirect · Held indirectly by Patricia Frist Elcan 2015 Annuity Trust I Disclosed balance after: 15,941 F1 · ownership.nature: Hercules Holding II ("Hercules") holds 68,912,077 shares of the common stock of HCA Healthcare, Inc. Hercules is held by a private investor group, including affiliates of HCA Inc. founder Dr. Thomas F. Frist Jr. The Reporting Person may be deemed to be a member of a group exercising voting and investment control over the shares of common stock of HCA Healthcare, Inc. held by Hercules. However, the Reporting Person disclaims membership in any such group and disclaims beneficial ownership of these securities, except to the extent of her pecuniary interest therein. F4 · ownership.nature: The Reporting Person is trustee of the Patricia Frist Elcan 2015 Annuity Trust I and may be deemed to be the beneficial owner of the 15,941 shares of common stock of HCA Healthcare, Inc. held by such trust. F5 · ownership.nature: On May 22, 2017, The Patricia Frist Elcan 2015 Annuity Trust I transferred an aggregate of 38,979.5002 units of Hercules to three grantor retained annuity trusts for the benefit of the Reporting Person's children. The Reporting Person is trustee of The Patricia Frist Elcan 2015 Annuity Trust I and the Reporting Person's spouse is trustee of the three grantor retained annuity trusts for the benefit of the Reporting Person's children. The Reporting Person may therefore be deemed the beneficial owner of the units of Hercules held by these grantor retained annuity trusts and therefore may be deemed to own indirectly the same number of shares of common stock of HCA Healthcare, Inc. Read SEC document |
| May 22, 2017 Filed Feb 14, 2018 17:38 UTC |
Elcan Patricia F10% owner
|
GiftCommon Stock, par value $0.01 per share | 9,366.67 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-18-010020 · doc5.xml · nonDerivative · entry 2 Elcan Patricia F · CIK 0001433376 · 10% owner 10b5-1 filing: Not disclosed Ownership: Indirect · Held indirectly through Hercules Holding II by Patricia Frist Elcan 2017 Annuity Trust IV Disclosed balance after: 778,055.67 F1 · ownership.nature: Hercules Holding II ("Hercules") holds 68,912,077 shares of the common stock of HCA Healthcare, Inc. Hercules is held by a private investor group, including affiliates of HCA Inc. founder Dr. Thomas F. Frist Jr. The Reporting Person may be deemed to be a member of a group exercising voting and investment control over the shares of common stock of HCA Healthcare, Inc. held by Hercules. However, the Reporting Person disclaims membership in any such group and disclaims beneficial ownership of these securities, except to the extent of her pecuniary interest therein. F3 · ownership.nature: The Reporting Person received a gift of 9,366.67 units of Hercules on May 22, 2017, which were subsequently transferred to The Patricia Frist Elcan 2017 Annuity Trust IV, of which she serves as trustee. Following receipt of this gift, the Reporting Person may be deemed the beneficial owner of the units of Hercules held by this trust and therefore may be deemed to own indirectly the same number of shares of common stock of HCA Healthcare, Inc. Read SEC document |
| May 17, 2017 Filed May 19, 2017 20:29 UTC |
Torres Kathryn A.SVP- Employer&Payer Engagement
|
SaleCommon Stock | 1,729 | $82.21 | $142,148.01 |
DisclosureSEC source: 0001209191-17-033942 · doc4.xml · nonDerivative · entry 1 Torres Kathryn A. · CIK 0001680636 · SVP- Employer&Payer Engagement 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 556 F1 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $82.21 to $82.22, inclusive. The reporting person undertakes to provide to HCA Healthcare, Inc., any security holder of HCA Healthcare, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| May 17, 2017 Filed May 19, 2017 20:27 UTC |
Morgan Sandra L.SVP-Provider Relations
|
SaleCommon Stock | 5,915 | $82.74 | $489,394.09 |
DisclosureSEC source: 0001209191-17-033940 · doc4.xml · nonDerivative · entry 1 Morgan Sandra L. · CIK 0001632836 · SVP-Provider Relations 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,419.8654 F1 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $82.7377 to $82.74, inclusive. The reporting person undertakes to provide to HCA Healthcare, Inc., any security holder of HCA Healthcare, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| May 15, 2017 Filed May 17, 2017 22:55 UTC |
Cuffe Michael S.President-Physician Services
|
Exercise / conversionNon-Qualified Stock Option (right to buy) · Derivative | 2,150 | $0.00 Strike: $17.33 | $0.00 |
DisclosureSEC source: 0001209191-17-033410 · doc4.xml · derivative · entry 3 Cuffe Michael S. · CIK 0001632835 · President-Physician Services 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 15,300 Underlying: Common Stock · 2,150 shares Expires 2021-11-02 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The option exercises and sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person. F2 · derivative.exercise_date: The option vested in two equal annual installments beginning on November 2, 2014. Read SEC document |
| May 15, 2017 Filed May 17, 2017 22:55 UTC |
Cuffe Michael S.President-Physician Services
|
SaleCommon Stock | 2,150 | $84.52 | $181,718.00 |
DisclosureSEC source: 0001209191-17-033410 · doc4.xml · nonDerivative · entry 2 Cuffe Michael S. · CIK 0001632835 · President-Physician Services 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,103.5974 F1 · kind: The option exercises and sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person. Read SEC document |
| May 15, 2017 Filed May 17, 2017 22:55 UTC |
Cuffe Michael S.President-Physician Services
|
Exercise / conversionCommon Stock | 2,150 | $17.33 | $37,259.50 |
DisclosureSEC source: 0001209191-17-033410 · doc4.xml · nonDerivative · entry 1 Cuffe Michael S. · CIK 0001632835 · President-Physician Services 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 12,253.5974 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The option exercises and sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person. Read SEC document |
| May 11, 2017 Filed May 15, 2017 22:48 UTC |
Morgan Sandra L.SVP-Provider Relations
|
Exercise / conversionStock Appreciation Right · Derivative | 4,900 | $0.00 Strike: $47.97 | $0.00 |
DisclosureSEC source: 0001209191-17-032479 · doc4.xml · derivative · entry 7 Morgan Sandra L. · CIK 0001632836 · SVP-Provider Relations 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 4,900 shares Expires 2024-02-05 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · derivative.exercise_date: The stock appreciation rights vested at the end of fiscal years 2014, 2015 and 2016 based upon the achievement of certain annual EBITDA performance targets. Read SEC document |
| May 11, 2017 Filed May 15, 2017 22:48 UTC |
Morgan Sandra L.SVP-Provider Relations
|
Exercise / conversionStock Appreciation Right · Derivative | 5,250 | $0.00 Strike: $47.97 | $0.00 |
DisclosureSEC source: 0001209191-17-032479 · doc4.xml · derivative · entry 6 Morgan Sandra L. · CIK 0001632836 · SVP-Provider Relations 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,750 Underlying: Common Stock · 5,250 shares Expires 2024-02-05 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_date: The stock appreciation rights vest in four equal annual installments beginning on February 5, 2015. Read SEC document |
| May 11, 2017 Filed May 15, 2017 22:48 UTC |
Morgan Sandra L.SVP-Provider Relations
|
Exercise / conversionStock Appreciation Right · Derivative | 8,075 | $0.00 Strike: $37.18 | $0.00 |
DisclosureSEC source: 0001209191-17-032479 · doc4.xml · derivative · entry 5 Morgan Sandra L. · CIK 0001632836 · SVP-Provider Relations 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 8,075 shares Expires 2023-02-06 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: The stock appreciation rights vested at the end of fiscal years 2013, 2014, 2015 and 2016 based upon the achievement of certain annual EBITDA performance targets. Read SEC document |
| May 11, 2017 Filed May 15, 2017 22:48 UTC |
Morgan Sandra L.SVP-Provider Relations
|
Exercise / conversionStock Appreciation Right · Derivative | 2,125 | $0.00 Strike: $37.18 | $0.00 |
DisclosureSEC source: 0001209191-17-032479 · doc4.xml · derivative · entry 4 Morgan Sandra L. · CIK 0001632836 · SVP-Provider Relations 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 2,125 shares Expires 2023-02-06 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_date: The stock appreciation rights vested in four equal annual installments beginning on February 6, 2014. Read SEC document |
| May 11, 2017 Filed May 15, 2017 22:48 UTC |
Morgan Sandra L.SVP-Provider Relations
|
Tax withholdingCommon Stock | 14,435 | $85.29 | $1,231,161.15 |
DisclosureSEC source: 0001209191-17-032479 · doc4.xml · nonDerivative · entry 3 Morgan Sandra L. · CIK 0001632836 · SVP-Provider Relations 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,334.8654 Read SEC document |
| May 11, 2017 Filed May 15, 2017 22:48 UTC |
Morgan Sandra L.SVP-Provider Relations
|
Exercise / conversionCommon Stock | 10,150 | $47.97 | $486,895.50 |
DisclosureSEC source: 0001209191-17-032479 · doc4.xml · nonDerivative · entry 2 Morgan Sandra L. · CIK 0001632836 · SVP-Provider Relations 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 22,769.8654 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| May 11, 2017 Filed May 15, 2017 22:48 UTC |
Morgan Sandra L.SVP-Provider Relations
|
Exercise / conversionCommon Stock | 10,200 | $37.18 | $379,236.00 |
DisclosureSEC source: 0001209191-17-032479 · doc4.xml · nonDerivative · entry 1 Morgan Sandra L. · CIK 0001632836 · SVP-Provider Relations 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 12,619.8654 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| May 11, 2017 Filed May 15, 2017 22:45 UTC |
Davis Jana JoustraSVP - Mktg. & Corp. Affairs
|
SaleCommon Stock | 8,302 | $85.02 | $705,836.04 |
DisclosureSEC source: 0001209191-17-032475 · doc4.xml · nonDerivative · entry 1 Davis Jana Joustra · CIK 0001513409 · SVP - Mktg. & Corp. Affairs 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 36,589 Read SEC document |
| May 10, 2017 Filed May 10, 2017 23:21 UTC |
Englebright Jane D.SVP and Chief Nursing Officer
|
SaleCommon Stock | 5,005 | $85.31 | $426,992.57 |
DisclosureSEC source: 0001209191-17-031415 · doc4.xml · nonDerivative · entry 5 Englebright Jane D. · CIK 0001632834 · SVP and Chief Nursing Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,632 F1 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $85.29 to $85.35, inclusive. The reporting person undertakes to provide to HCA Healthcare, Inc., any security holder of HCA Healthcare, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| May 10, 2017 Filed May 12, 2017 22:16 UTC |
Torres Kathryn A.SVP- Employer&Payer Engagement
|
Exercise / conversionStock Appreciation Right · Derivative | 4,300 | $0.00 Strike: $22.95 | $0.00 |
DisclosureSEC source: 0001209191-17-032131 · doc4.xml · derivative · entry 4 Torres Kathryn A. · CIK 0001680636 · SVP- Employer&Payer Engagement 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 4,300 shares Expires 2022-02-08 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: The stock appreciation rights vested at the end of fiscal years 2014 and 2015 based upon the achievement of certain annual EBITDA performance targets. Read SEC document |
| May 10, 2017 Filed May 12, 2017 22:16 UTC |
Torres Kathryn A.SVP- Employer&Payer Engagement
|
SaleCommon Stock | 1,196 | $85.69 | $102,489.19 |
DisclosureSEC source: 0001209191-17-032131 · doc4.xml · nonDerivative · entry 3 Torres Kathryn A. · CIK 0001680636 · SVP- Employer&Payer Engagement 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,285 F1 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $85.69 to $85.695, inclusive. The reporting person undertakes to provide to HCA Healthcare, Inc., any security holder of HCA Healthcare, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| May 10, 2017 Filed May 12, 2017 22:16 UTC |
Torres Kathryn A.SVP- Employer&Payer Engagement
|
Tax withholdingCommon Stock | 2,015 | $85.56 | $172,403.40 |
DisclosureSEC source: 0001209191-17-032131 · doc4.xml · nonDerivative · entry 2 Torres Kathryn A. · CIK 0001680636 · SVP- Employer&Payer Engagement 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,481 Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.